A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trialCesar A. Santa‐Maria, Vered Stearns, Amanda L. Blackford et al.|Breast Cancer Research and Treatment|2018Cited by 28